MedPath

Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT

Completed
Conditions
PostTraumatic Stress Disorder
Psychotherapy
Borderline Personality Disorder
Dropout
Interventions
Behavioral: Dialectical Behavior Therapy
Registration Number
NCT03018639
Lead Sponsor
Evangelisches Krankenhaus Bielefeld gGmbH
Brief Summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria
  • three or more criteria for BPD as defined by DSM-IV (Borderline Personality characteristics; BPC)
Exclusion Criteria
  • inability to contract and consent,
  • other severe mental disorders (bipolar disorder, acute psychosis),
  • current alcohol,
  • illicit or not prescribed drug use,
  • simultaneous participation in other treatment studies,
  • pregnancy or breastfeeding,
  • an inability to negotiate a non-suicide agreement,
  • ongoing traumatic contact with the perpetrator, and
  • a Body Mass Index < 16.5.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Dialectical Behavior TherapyDialectical Behavior TherapyThe program's purpose is to help patients achieve the following therapeutic goals: (1) reduction of suicidal behaviors, (2) reduction of therapy-interfering behaviors, and (3) other risky or destabilizing behaviors. Standard DBT aims to achieve these goals by (1) conveying behavioral capabilities (skills), (2) motivation for applying these skills, (3) generalization of learned skills to the patient's natural environment, (4) structuring the treatment environment to reinforce functional behavior, and (5) conveying therapeutic resources and motivation to effectively treat patients with BPD.
Primary Outcome Measures
NameTimeMethod
Dropout10 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Research Department

🇩🇪

Bielefeld, Germany

© Copyright 2025. All Rights Reserved by MedPath